In recent years, the medical community has witnessed what many are calling a “Psychedelic Renaissance.” Once relegated to the fringes of counterculture and strictly prohibited by global governments, substances like psilocybin and MDMA are now receiving FDA “Breakthrough Therapy” status. This designation is reserved for drugs that demonstrate substantial improvement over existing therapies for serious...